✦ LIBER ✦

Lack of vasopressin action on splanchnic hemodynamics during bleeding: A study in conscious, portal hypertensive rats

✍ Scribed by Dr. Dominique Valla; Catherine Girod; Samuel S. Lee; Alain Braillon; Didier Lebrec

Book ID: 118283747
Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 657 KB
Volume: 8
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840080104

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of the V1a vasopressin agonist F

Effects of the V1a vasopressin agonist F-180 on portal hypertension-related bleeding in portal hypertensive rats

✍ Josephine Morales; Eduardo Moitinho; Juan G. Abraldes; Mercedes Fernández; Jaime 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Effects of ritanserin, a selective and s

Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats

✍ Frederik Nevens; M. Pilar Pizcueta; Mercedes Fernández; Dr. Jaime Bosch; Joan Ro 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Serotonergic mechanisms have recently been implicated in the pathogenesis of portal hypertension; this suggests that blockade of serotonin S2 receptors may be a new approach for the pharmacological therapy of portal hypertension. This study was aimed at investigating the effects of ritanserin, a sel

Effects of F-180, a new selective vasoco

Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension

✍ Cristina Bernadich; Juan-Carlos Bandi; Per Melin; Jaime Bosch 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

The effect of the combination of nitrogl

The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model

✍ Richard J. Kroeger; Roberto J. Groszmann 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 650 KB

Present investigations support major contributions from increases in both portal blood flow and portal vascular resistance in the mechanism that maintains portal hypertension. B-Adrenergic blockers have been shown to reduce the elevated portal blood flow component. The possibility that nitroglycerin